Philip A Beer

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Diffuse Large B Cell Lymphoma

Acute Lymphoblastic Leukemia

Top Venues

Leukemia & lymphoma

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Christina Pfeiffer, Alexander Michael Grandits, Hélène Asnagli, Anja Schneller, Julia Huber, Niklas Zojer, Martin Schreder, Andrew E Parker, Arnold Bolomsky, Philip A Beer, Heinz Ludwig
CTPS1 is a novel therapeutic target in multiple myeloma which synergizes with inhibition of CHEK1, ATR or WEE1. Leukemia (2023)
Raffaella Casolino, Salvatore Paiella, Danila Azzolina, Philip A Beer, Vincenzo Corbo, Giulia Lorenzoni, Dario Gregori, Talia Golan, Chiara Braconi, Fieke E M Froeling, Michele Milella, Aldo Scarpa, Antonio Pea, Giuseppe Malleo, Roberto Salvia, Claudio Bassi, David K Chang, Andrew V Biankin
Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (23) (2021)
Loretta J Nastoupil, Sattva S Neelapu, Richard Eric Davis, Felipe Samaniego, Nathan Hale Fowler, Jason R Westin, Hun Ju Lee, Michael L Wang, Fredrick Hagemeister, Alexander R L Cecil, James Dow, Kemal Haque, Franck A Silva, Andrew Whale, Letitia Lensun, Elisabeth A Bone, Hilary McElwaine-Johnn, Philip A Beer
Preclinical and phase I studies of KA2237, a selective and potent inhibitor of PI3K β/δ in relapsed refractory B cell lymphoma. Leukemia & lymphoma (2021)